Truist analyst Michael Lewis raised the firm’s price target on BXP (BXP) to $83 from $77 and keeps a Hold rating on the shares. The firm is adjusting its estimates as it is assuming BXP can get closer to pre-COVID occupancy levels in later periods of its five-year model, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BXP:
- BXP price target raised to $83 from $77 at Truist
- Trump Trade: Trump Media considers developing crypto payment service
- BXP price target raised to $89 from $88 at Barclays
- American upgraded, Regeneron initiated: Wall Street’s top analyst calls
- Compass Point upgrades BXP to Buy after relative underperformance